Core Binding Factor Acute Myeloid Leukemia

Core Binding Factor Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

175 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05504408	Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia	unknown	—	200	The First Affiliated Hospital of Soochow UniversityOTHER	1	Oct 10, 2023	clinicaltrials
NCT05821738	Avapritinib in CBF-AML With KIT Mutations	unknown	Phase 2	50	The First Affiliated Hospital of Soochow UniversityOTHER	1	May 9, 2023